BMI OrganBank

02/19/2026

Thank you, Matt O’Brien of Piper Sandler, for visiting BMI OrganBank and the Duke University DEVOL Lab to discuss BMI OrganBank’s room-temperature machine perfusion and the evolving landscape of organ preservation.

The conversation allowed for an open exchange of perspectives on emerging technologies in transplantation and the dynamics shaping the field.

Thoughtful dialogue across research, clinical practice, and industry perspectives helps move the field forward.

02/17/2026

At the American Society of Transplant Surgeons (ASTS) Winter Symposium, BMI OrganBank presented new preclinical data from a head-to-head study evaluating room-temperature machine perfusion with OrganBank Kidney® against hypothermic machine preservation in a controlled transplant model.
This data built on prior preclinical work as the platform moves toward clinical evaluation later this year.

Our full analysis outlines:
• The head-to-head study design
• Why delayed graft function remains a critical unmet need
• How active preservation may expand transplant confidence — and how these findings fit into the broader evolution of transplant preservation

Read the full update: https://bmiorganbank.com/head-to-head-preclinical-data-demonstrate-reduced-delayed-graft-function-with-organbank-kidney/

Carrie DiMarzio
Duke University Hospital

Compared to hypothermic machine preservation, OrganBank Kidney showed more consistent early graft performance in a controlled preclinical transplant model BMI OrganBank recently presented new preclinical data at the American Society of Transplant Surgeons (ASTS) Winter Symposium evaluating its Organ...

01/19/2026

We’re pleased to share that Nader Abraham, MD (Duke University School of Medicine) will be presenting this Saturday at the American Society of Transplant Surgeons - ASTS Winter Symposium.

His presentation will highlight recent investigational work in extended organ preservation that reflects meaningful progress in the field. Details will be shared during the presentation, and we will release more information afterward.

More to come.

01/13/2026

Carrie DiMarzio shares why her work starts with people, not technology.
Drawing on her background in engineering, biomedical research, and patient advocacy, Carrie reflects on how urgency, limited information, and system-level constraints shape the real experiences of patients and care teams every day—and why she believes transplant care can be designed to work better.
This is a look at the passion and purpose behind her work.

Read the story: https://bmiorganbank.com/carrie-dimarzio_ceo-and-co-founder/

With thanks to Wake Forest Institute for Regenerative Medicine, Innovation Quarter, and Sparq for hosting our filming.

01/08/2026

What drives leadership in one of medicine’s most complex and high-stakes fields?

In our latest Leadership Spotlight, Carrie DiMarzio shares how her background in engineering, biomedical research, and patient advocacy shapes her approach to organ preservation and transplant innovation.

Carrie explains why many viable donor organs still go unused—not because of a donor shortage, but because of time constraints, logistics, and limited information—and why rethinking how organs are preserved and assessed is critical for supporting better decision-making across the transplant system.

This story isn’t just about technology. It’s about improving quality of life, supporting clinicians, and designing a system that gives donated organs a better chance to reach the people who need them.

Read the full Leadership Spotlight here: https://bmiorganbank.com/carrie-dimarzio_ceo-and-co-founder/

12/12/2025

The National Kidney Foundation’s leadership brings firsthand understanding of the challenges patients and families face — and that lived experience drives their advocacy and impact. We’re proud to support NKF and stand alongside leaders driving meaningful progress, and it’s inspiring to see their work recognized on a stage like Nasdaq.

Watch the video to hear their perspective and the insight that comes from living this mission every day.



- Carrie DiMarzio, Robert Neusner, Volovich, CFA

11/26/2025

We're building the future of organ preservation — one breakthrough at a time. Powered by science. Driven by innovation. Grounded in compassion. Watch the video. Join the movement.

Special Thanks to: National Kidney Foundation and American Society of Nephrology

11/20/2025

Recognizing the incredible work of Dr. Barbas — a member of our leadership team and co-inventor of our technology. His scientific vision and commitment continue to advance the future of organ preservation. Thank you to HonorBridge for highlighting his contributions and helping bring greater visibility to this important mission.

Hear more from Dr. Barbas about the importance of innovation on saving and healing lives: https://bit.ly/47xu7Ik

Duke Health

09/24/2025

We’re proud to share that the National Kidney Foundation Innovation Fund has made a strategic investment in BMI OrganBank.

This investment aims to accelerate our innovative kidney preservation technology – using our novel room temperature machine perfusion (RTMP) platform . The funding will support the start of our upcoming clinical study.

Together with NKF, we aim to bring more lifesaving kidneys to patients and transform transplant care.

Learn more: https://www.kidney.org/press-room/nkf-innovation-fund-invests-bmi-organbank-to-advance-breakthrough-kidney-transplant

08/07/2025

The richness of our conversations at hashtag reflects the transformational moment we’re in for transplant medicine. It was an honor to speak with pioneers like Professor Rutger Ploeg, MD PhD FRCS FEBS, Dr. David Axelrod, and Dr. David Ge**er—leaders whose contributions continue to shape the future of organ transplantation.

Professor Ploeg is a Pioneer in the transplantation arena as well as a founding member of The Quality in Organ Donation - QUOD initiative, a national consortium in the United Kingdom, committed to promote research and facilitate service development in organ donation and transplantation. The BMI and QUOD leadership share a deep commitment to advancing the outcomes for patients undergoing organ transplantation.

We’ve left WTC feeling inspired and grateful. If we didn’t get the chance to connect during the conference, we’d still love to talk. Reach out anytime at info@bmiorganbank.com.

08/05/2025

BMI OrganBank is on the ground at in San Francisco!
CEO Carrie DiMarzio, COO Bob Neusner, and CMO Dr. David Ge**er are here to meet with OPO leaders, transplant innovators, and future partners to discuss organ perfusion technology, innovations in transplantation, and partnership opportunities with BMI OrganBank.

Want to connect during the conference?
Email us at info@bmiorganbank.com to schedule a meeting.

08/04/2025

BREAKING NEWS: BMI OrganBank’s kidney preservation device has received FDA Breakthrough Device Designation, recognizing its great promise to transform kidney transplant care.

Our room temperature machine perfusion (RTMP) platform aims to extend preservation times and improve kidney function assessment, with the goal of expanding access to lifesaving transplants.

A clinical study is planned for early next year.

Learn more: https://bmiorganbank.com/bmi-organbank-secures-fda-breakthrough-device-designation-for-innovative-kidney-transplant-technology/

Contact: info@bmiorganbank.com

Carrie DiMarzio, Co-Founder & CEO
Robert Neusner, President & COO